Tag: BlueWind Medical
US FDA grants de novo marketing request to BlueWind’s Revi system...
BlueWind Medical has announced that the US Food and Drug Administration (FDA) has granted a de novo marketing request for the Revi system—a “transformative”...
BlueWind Medical completes patient enrolment in OASIS study
BlueWind Medical has announced the successful completion of patient enrolment in the OASIS pivotal clinical study that will assess the company’s innovative Renova iStim...
